Literature DB >> 7259803

Antibiotic therapy of septic bursitis. Its implication in the treatment of septic arthritis.

G Ho, E Y Su.   

Abstract

Infected olecranon, prepatellar, and infrapatellar bursae offer a unique opportunity to study the response of a closed-space infection to antibiotic therapy. Using percutaneous needle aspirations, serial bursal fluids were cultured. The length of time necessary to achieve culture sterility with antibiotic therapy (an average of 4 days in 25 patients) was correlated with the duration of symptoms prior to diagnosis (r = 0.68, P less than 0.001). In patients treated within 2 weeks from onset of symptoms, bursal fluid sterility was achieved within 1 week of therapy, while longer duration of symptoms was associated with delayed response. When antibiotic therapy was continued for 5 additional days after documented culture sterility, all 19 patients in the prospective trial were cured (average followup period of 6.8 months). In septic bursitis, the effects of delay in treatment are deleterious by prolonging culture-positivity despite adequate antibiotic therapy. By analogy, delay in treatment of septic arthritis may result in the persistence of an adverse environment which can lead to further articular damage. After accurate diagnosis of septic bursitis, a therapeutic approach consisting of prompt and appropriate antibiotic usage, frequent needle drainage, and treatment duration based on the culture results of serial aspirations is effective and may be applicable in the management of certain nongonococcal bacterial joint infections.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259803     DOI: 10.1002/art.1780240707

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

Review 1.  Olecranon and prepatellar bursitis. Diagnosis and treatment.

Authors:  J H McAfee; D L Smith
Journal:  West J Med       Date:  1988-11

2.  Septic olecranon and prepatellar bursitis in hockey players: a report of three cases.

Authors:  Taylor Tuff; Karen Chrobak
Journal:  J Can Chiropr Assoc       Date:  2016-12

Review 3.  Olecranon bursitis: a systematic overview.

Authors:  John R Blackwell; Bruce A Hay; Alexander M Bolt; Stuart M Hay
Journal:  Shoulder Elbow       Date:  2014-05-06

Review 4.  A systematic review of the management of acute pyogenic flexor tenosynovitis.

Authors:  A M Giladi; S Malay; K C Chung
Journal:  J Hand Surg Eur Vol       Date:  2015-02-10

5.  Septic bursitis in systemic lupus erythematosus.

Authors:  R Greene; R Kaufman; F P Quismorio
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

6.  Management and outcome of infective prepatellar bursitis.

Authors:  J Wilson-MacDonald
Journal:  Postgrad Med J       Date:  1987-10       Impact factor: 2.401

7.  Evaluation of current treatment regimens for prepatellar and olecranon bursitis in Switzerland.

Authors:  S F Baumbach; H Wyen; C Perez; K-G Kanz; I Uçkay
Journal:  Eur J Trauma Emerg Surg       Date:  2012-11-08       Impact factor: 3.693

8.  Biomechanical effects of steroid injections used to treat pyogenic flexor tenosynovitis.

Authors:  Blake R Turvey; Paul S Weinhold; Reid W Draeger; Donald K Bynum; Laurence E Dahners
Journal:  J Orthop Surg Res       Date:  2012-10-09       Impact factor: 2.359

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.